An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Century Therapeutics (NASDAQ: IPSC) will participate in Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit with a fireside chat and panel discussion. The events will focus on iPSC-derived cell therapies in immuno-oncology and autoimmune and inflammatory diseases.
Century Therapeutics (NASDAQ: IPSC) parteciperà al 8° Summit Annuale di Chardan sulla Medicina Genetica e la Produzione di Terapie Cellulari con una conversazione informale e una discussione di panel. Gli eventi si concentreranno sulle terapie cellulari derivate da iPSC in immuno-oncologia e malattie autoimmuni e infiammatorie.
Century Therapeutics (NASDAQ: IPSC) participará en la 8va Cumbre Anual de Chardan sobre Medicinas Genéticas y Fabricación de Terapias Celulares con un chat junto al fuego y un panel de discusión. Los eventos se centrarán en terapias celulares derivadas de iPSC en inmuno-oncología y enfermedades autoinmunes e inflamatorias.
Century Therapeutics (NASDAQ: IPSC)은 Chardan의 제8회 유전 의학 및 세포 치료제 제조 정상회의에 화롯불 대화와 패널 토론으로 참여할 예정입니다. 이 행사는 면역 종양학 및 자가면역 및 염증성 질환에서 iPSC 유래 세포 치료에 중점을 둘 것입니다.
Century Therapeutics (NASDAQ : IPSC) participera au 8ème Sommet Annuel de Chardan sur les Médicines Génétiques et la Fabrication de Thérapies Cellulaires avec un échange informel et une discussion en panel. Les événements se concentreront sur les thérapies cellulaires dérivées d'iPSC en immuno-oncologie et sur les maladies auto-immunes et inflammatoires.
Century Therapeutics (NASDAQ: IPSC) wird am 8. jährlichen Gipfeltreffen von Chardan zur Genetischen Medizin und Zelltherapieherstellung mit einem Kamingespräch und einer Podiumsdiskussion teilnehmen. Die Veranstaltungen werden sich auf aus iPSC abgeleitete Zelltherapien in der Immuno-Onkologie sowie auf autoimmune und entzündliche Krankheiten konzentrieren.
Positive
None.
Negative
None.
PHILADELPHIA, April 23, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune and inflammatory disease, today announced that members of the management team will participate in a virtual fireside chat and panel at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit, details of the presentations are as follows:
Fireside Chat on Tuesday, April 30, 2024, at 1:30pm ET
Panel titled “iPSCs Unleashed: Mastering Manufacturing for Next-Gen Cell Therapies” on Tuesday, April 30, 2024, at 3:30pm ET
A replay of the events will be available on the “Events & Presentations” page in the “Investors” section of the Company’s website at https://investors.centurytx.com/events-and-presentations and will be available for 90 days following the events.
About Century Therapeutics
Century Therapeutics (NASDAQ: IPSC) is harnessing the power of adult stem cells to develop curative cell therapy products for cancer and autoimmune and inflammatory diseases that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived cell product candidates are designed to specifically target hematologic and solid tumor cancers, with a broadening application to autoimmune and inflammatory diseases. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of cancer and autoimmune and inflammatory disease care. For more information on Century Therapeutics please visit www.centurytx.com.
When will Century Therapeutics participate in Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit?
Century Therapeutics will participate in the summit on Tuesday, April 30, 2024.
What is the topic of the fireside chat?
The fireside chat will focus on iPSC-derived cell therapies in immuno-oncology and autoimmune and inflammatory diseases.
Where can the replay of the events be accessed?
The replay will be available on the 'Events & Presentations' page in the 'Investors' section of Century Therapeutics' website at https://investors.centurytx.com/events-and-presentations for 90 days following the events.
Century Therapeutics, Inc. specializes in adult stem cells to develop curative cell therapy products for cancer that overcome the limitations of first generation cell therapies as well as provides testing and research services.
